Discover PF-06658607, an alkynylated irreversible Bruton’s tyrosine kinase (BTK) inhibitor designed for research into covalent kinase inhibition.
View the product details here: ebc.enamine.net/molecule-produ…
PF-06658607 selectively targets the active-site cysteine within the ATP-binding pocket of BTK, forming a covalent bond and providing a valuable tool for investigating irreversible kinase inhibition.
A distinctive feature of this compound is its alkyne functional group, which enables the attachment of azide-containing detection probes through copper-catalyzed click chemistry. This approach makes PF-06658607 particularly useful for identifying and profiling potential off-target interactions of covalent kinase inhibitors in cancer cells.
Learn more about PF-06658607: pubmed.ncbi.nlm.nih.gov/25038787/
Explore Enamine’s @pfizer Reference Compound Collection to discover a diverse range of bioactive molecules for research across multiple therapeutic areas: ebc.enamine.net/categorized-pr…
View the product details here: ebc.enamine.net/molecule-produ…
PF-06658607 selectively targets the active-site cysteine within the ATP-binding pocket of BTK, forming a covalent bond and providing a valuable tool for investigating irreversible kinase inhibition.
A distinctive feature of this compound is its alkyne functional group, which enables the attachment of azide-containing detection probes through copper-catalyzed click chemistry. This approach makes PF-06658607 particularly useful for identifying and profiling potential off-target interactions of covalent kinase inhibitors in cancer cells.
Learn more about PF-06658607: pubmed.ncbi.nlm.nih.gov/25038787/
Explore Enamine’s @pfizer Reference Compound Collection to discover a diverse range of bioactive molecules for research across multiple therapeutic areas: ebc.enamine.net/categorized-pr…